Abstract
Cancer risks and tumor types in male BRCA1 and BRCA2 mutation carriers are still unsettled. Cancer risks in men who were found to harbor a BRCA1 (n = 150) or a BRCA2 (n = 88) mutation or both (n = 2) were assessed by cross referencing with data on cancer occurrence in the Israeli National Cancer Registry. Incidence rates in mutation carriers were compared with men who were counseled, genotyped, and found not to harbor the familial mutation (true negative n = 122), and with standardized incidence rates (SIRs). Of 210 cancer-free individuals at initial counseling, 11 cancers were diagnosed after a mean follow-up of 5.06 ± 4.1 years (1064 person/years) compared with 1/122 in a BRCA true-negative man. The SIR for all BRCA1/2 mutation carriers compared with the rates in the general population were elevated for pancreatic cancer [2.97 (95 % CI 1.83-4.29)] and breast cancer [16.44 (95 % CI 9.65-26.24)]. For prostate cancer these rates were 0.59 (95 % CI 0.4-0.84). Jewish BRCA1/2 mutation carriers are at an increased risk for breast and pancreatic, but not prostate cancer. These cancer risks and the consequent recommendations, if validated, should be transmitted to carriers at test result disclosure.
References
Aug 5, 1999·Journal of the National Cancer Institute·UNKNOWN Breast Cancer Linkage Consortium
Sep 19, 2002·Journal of the National Cancer Institute·Deborah ThompsonUNKNOWN Breast Cancer Linkage Consortium
Dec 11, 2002·American Journal of Human Genetics·Stephen M EdwardsUNKNOWN British Association of Urological Surgeons Section of Oncology
Feb 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander LiedeSteven A Narod
May 8, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomas KirchhoffKenneth Offit
May 8, 2004·Familial Cancer·Jan LubinskiSteven A Narod
Dec 7, 2006·Journal of the National Cancer Institute·Harvey A RischSteven A Narod
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ilir AgalliuElaine A Ostrander
Nov 29, 2007·Journal of the National Cancer Institute·Yu Chuan TaiSining Chen
Dec 20, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Cezary CybulskiJan Lubiński
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David J GallagherKenneth Offit
Jul 1, 2010·Journal of Medical Genetics·D G R EvansF Lalloo
Apr 5, 2011·Journal of Mammary Gland Biology and Neoplasia·Andrew Y Shuen, William D Foulkes
Apr 27, 2011·The Prostate·Laura FachalAna Vega
Dec 22, 2011·Familial Cancer·A MoranD G R Evans
Mar 9, 2012·Breast Cancer Research and Treatment·Yael LaitmanEitan Friedman
Nov 9, 2012·Gut·Marcia Irene CantoUNKNOWN International Cancer of Pancreas Screening (CAPS) Consortium
Dec 26, 2013·Oncology Nursing Forum·Suzanne M Mahon
Mar 14, 2014·Pancreas·Anchal SudNalini M Guda
Jul 18, 2014·World Journal of Gastrointestinal Endoscopy·Gabriele LamiAndrea Galli
Sep 17, 2014·Cancer·Jacqueline MerschJennifer K Litton
Citations
May 18, 2019·Andrology·G A KanakisN Jørgensen
Mar 15, 2019·British Journal of Cancer·Tsuyoshi HamadaBrian M Wolpin
Jul 3, 2020·JAMA Oncology·Valentina SilvestriLaura Ottini
Jan 21, 2021·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Margherita PizzatoCarlo La Vecchia
Oct 14, 2021·Breast Cancer Research and Treatment·Reem S ChamseddineKevin S Hughes